Butanamide, 4-(4-chloro-3-methylphenoxy)-N-(5-chloro-2-thiazolyl)-

Request For Quotation
Butanamide, 4-(4-chloro-3-methylphenoxy)-N-(5-chloro-2-thiazolyl)- Suppliers list
Company Name: Nantong Hanfang Biotechnology Co. , Ltd.  
Tel: hanfangpharma@126.com 18017580634
Email: hanfangpharma@126.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: TargetMol Chemicals Inc.  
Tel: 13564774135
Email: marketing@targetmol.com

Butanamide, 4-(4-chloro-3-methylphenoxy)-N-(5-chloro-2-thiazolyl)- manufacturers
Butanamide, 4-(4-chloro-3-methylphenoxy)-N-(5-chloro-2-thiazolyl)- Basic information
Product Name:Butanamide, 4-(4-chloro-3-methylphenoxy)-N-(5-chloro-2-thiazolyl)-
Synonyms:Butanamide, 4-(4-chloro-3-methylphenoxy)-N-(5-chloro-2-thiazolyl)-;HIV-1 inhibitor-36
CAS:2170506-18-8
MF:C14H14Cl2N2O2S
MW:345.24
EINECS:
Product Categories:
Mol File:2170506-18-8.mol
Butanamide, 4-(4-chloro-3-methylphenoxy)-N-(5-chloro-2-thiazolyl)- Structure
Butanamide, 4-(4-chloro-3-methylphenoxy)-N-(5-chloro-2-thiazolyl)- Chemical Properties
density 1.398±0.06 g/cm3(Predicted)
pka8.74±0.50(Predicted)
Safety Information
MSDS Information
Butanamide, 4-(4-chloro-3-methylphenoxy)-N-(5-chloro-2-thiazolyl)- Usage And Synthesis
UsesHIV-1 inhibitor-36 (Compound 2) is a potent HIV-1. HIV-1 inhibitor-36 has the potential for further development as novel latency reversing agents[1].
References[1] Nguyen W, et al. Optimization of 5-substituted thiazolyl ureas and 6-substituted imidazopyridines as potential HIV-1 latency reversing agents. Eur J Med Chem. 2020 Jun 1;195:112254. DOI:10.1016/j.ejmech.2020.112254
Butanamide, 4-(4-chloro-3-methylphenoxy)-N-(5-chloro-2-thiazolyl)- Preparation Products And Raw materials
Tag:Butanamide, 4-(4-chloro-3-methylphenoxy)-N-(5-chloro-2-thiazolyl)-(2170506-18-8) Related Product Information
Doxorubicin hydrochloride Ivermectin PLERIXAFOR Gag-Pol polyprotein, HIV (440a.a, His) P24 protein, HIV-1 (BAH97658, HIS) Rev Protein, HIV-1 group M subtype C (GST)